These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 19183313)
21. Treatment of venous ulcers with pentoxifylline: a 12-month, double-blind, placebo controlled trial. Microcirculation and healing. De Sanctis MT; Belcaro G; Cesarone MR; Ippolito E; Nicolaides AN; Incandela L; Geroulakos G Angiology; 2002; 53 Suppl 1():S49-51. PubMed ID: 11865837 [TBL] [Abstract][Full Text] [Related]
22. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Shukrimi A; Sulaiman AR; Halim AY; Azril A Med J Malaysia; 2008 Mar; 63(1):44-6. PubMed ID: 18935732 [TBL] [Abstract][Full Text] [Related]
23. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers. Zimny S; Schatz H; Pfohl M Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):191-4. PubMed ID: 15127323 [TBL] [Abstract][Full Text] [Related]
24. Low molecular weight heparin seems to improve local capillary circulation and healing of chronic foot ulcers in diabetic patients. Jörneskog G; Brismar K; Fagrell B Vasa; 1993; 22(2):137-42. PubMed ID: 8391741 [TBL] [Abstract][Full Text] [Related]
25. Phototherapy promotes healing of chronic diabetic leg ulcers that failed to respond to other therapies. Minatel DG; Frade MA; França SC; Enwemeka CS Lasers Surg Med; 2009 Aug; 41(6):433-41. PubMed ID: 19588536 [TBL] [Abstract][Full Text] [Related]
26. Pilot trial of biovance collagen-based wound covering for diabetic ulcers. Letendre S; LaPorta G; O'Donnell E; Dempsey J; Leonard K Adv Skin Wound Care; 2009 Apr; 22(4):161-6. PubMed ID: 19325275 [TBL] [Abstract][Full Text] [Related]
27. A randomized controlled trial to examine the efficacy and safety of a new super-oxidized solution for the management of wide postsurgical lesions of the diabetic foot. Piaggesi A; Goretti C; Mazzurco S; Tascini C; Leonildi A; Rizzo L; Tedeschi A; Gemignani G; Menichetti F; Del Prato S Int J Low Extrem Wounds; 2010 Mar; 9(1):10-5. PubMed ID: 20207618 [TBL] [Abstract][Full Text] [Related]
28. Apligraf in the treatment of neuropathic diabetic foot ulcers. Edmonds M; Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997 [TBL] [Abstract][Full Text] [Related]
29. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Chantelau E; Tanudjaja T; Altenhöfer F; Ersanli Z; Lacigova S; Metzger C Diabet Med; 1996 Feb; 13(2):156-9. PubMed ID: 8641121 [TBL] [Abstract][Full Text] [Related]
30. The use of antibiotics in the diabetic foot. Edmonds M; Foster A Am J Surg; 2004 May; 187(5A):25S-28S. PubMed ID: 15147988 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Wymer JP; Simpson J; Sen D; Bongardt S; Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870 [TBL] [Abstract][Full Text] [Related]
32. Ketanserin in the treatment of diabetic foot ulcer with severe peripheral vascular disease. Apelqvist J; Castenfors J; Larsson J; Stenström A; Persson G Int Angiol; 1990; 9(2):120-4. PubMed ID: 2254674 [TBL] [Abstract][Full Text] [Related]
33. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP; Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297 [TBL] [Abstract][Full Text] [Related]
34. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Kalani M; Apelqvist J; Blombäck M; Brismar K; Eliasson B; Eriksson JW; Fagrell B; Hamsten A; Torffvit O; Jörneskog G Diabetes Care; 2003 Sep; 26(9):2575-80. PubMed ID: 12941721 [TBL] [Abstract][Full Text] [Related]
35. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Khaodhiar L; Dinh T; Schomacker KT; Panasyuk SV; Freeman JE; Lew R; Vo T; Panasyuk AA; Lima C; Giurini JM; Lyons TE; Veves A Diabetes Care; 2007 Apr; 30(4):903-10. PubMed ID: 17303790 [TBL] [Abstract][Full Text] [Related]
36. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Hong JP; Jung HD; Kim YW Ann Plast Surg; 2006 Apr; 56(4):394-8; discussion 399-400. PubMed ID: 16557070 [TBL] [Abstract][Full Text] [Related]
37. Effect of WF10 (immunokine) on diabetic foot ulcer therapy: a double-blind, randomized, placebo-controlled trial. Yingsakmongkol N; Maraprygsavan P; Sukosit P J Foot Ankle Surg; 2011; 50(6):635-40. PubMed ID: 21723750 [TBL] [Abstract][Full Text] [Related]
38. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area. Ince P; Game FL; Jeffcoate WJ Diabetes Care; 2007 Mar; 30(3):660-3. PubMed ID: 17327337 [TBL] [Abstract][Full Text] [Related]
39. Decubitus direct current treatment (DDCT) of pressure ulcers: results of a randomized double-blinded placebo controlled study. Adunsky A; Ohry A; Arch Gerontol Geriatr; 2005; 41(3):261-9. PubMed ID: 15998547 [TBL] [Abstract][Full Text] [Related]
40. Healing effect of ketanserin on chronic leg ulcers in patients with diabetes. Quatresooz P; Kharfi M; Paquet P; Vroome V; Cauwenbergh G; Piérard GE J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):277-81. PubMed ID: 16503887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]